Bleomycin-induced chromosome breaks as a risk marker for lung cancer: A case-control study with population and hospital controls

Yun Ling Zheng, Christopher A. Loffredo, Zhipeng Yu, Raymond T. Jones, Mark J. Krasna, Anthony J. Alberg, Rex Yung, Donna Perlmutter, Lindsey Enewold, Curtis C. Harris, Peter G. Shields

Research output: Contribution to journalArticle

Abstract

Environmental exposure to carcinogens and individual susceptibility play significant roles in cancer risk. Suboptimal DNA repair capability, measured by quantifying mutagen-induced chromosome breaks, might explain variable host susceptibility to environmental carcinogens. In an ongoing lung cancer case-control study, we compared individual sensitivity to bleomycin-induced chromosome breaks in 152 non-small cell lung cancer patients with 94 population controls and 85 hospital controls with no history of cancer. Mutagen sensitivity was measured by mean number of chromatid breaks per cell in cultured peripheral blood lymphocytes treated with bleomycin. Non-parametric tests and χ2 tests were used to determine the statistical significance of the crude case-control comparisons, followed by logistic regression to adjust for important covariates. The mean number of bleomycin-induced breaks per cell was 1.01 for the cases compared with 0.86 for hospital controls (P <0.01) and 0.89 for population controls (P <0.01). The mean number of breaks per cell was 1.01 for those >65 years old and 0.81 for those ≤65 years old (P <0.01) among population controls. Defining bleomycin sensitive as >0.84 break/cell (the median level in population controls), 67% of the cases were bleomycin sensitive compared with 49% of the hospital controls [adjusted odds ratio (OR) = 2.69, 95% confidence interval (CI) = 1.44, 5.04], and 51% of the population controls (adjusted OR = 2.18, 95% CI = 1.13, 4.21). Our data indicate that the increased number of bleomycin-induced chromosome breaks was significantly associated with an increased risk of lung cancer in the first 331 subjects.

Original languageEnglish (US)
Pages (from-to)269-274
Number of pages6
JournalCarcinogenesis
Volume24
Issue number2
DOIs
StatePublished - Feb 1 2003

Fingerprint

Chromosome Breakage
Population Control
Bleomycin
Case-Control Studies
Lung Neoplasms
Mutagens
Odds Ratio
Confidence Intervals
Environmental Carcinogens
Chromatids
Environmental Exposure
Non-Small Cell Lung Carcinoma
DNA Repair
Carcinogens
Cultured Cells
Neoplasms
Logistic Models
Lymphocytes

ASJC Scopus subject areas

  • Cancer Research

Cite this

Zheng, Y. L., Loffredo, C. A., Yu, Z., Jones, R. T., Krasna, M. J., Alberg, A. J., ... Shields, P. G. (2003). Bleomycin-induced chromosome breaks as a risk marker for lung cancer: A case-control study with population and hospital controls. Carcinogenesis, 24(2), 269-274. https://doi.org/10.1093/carcin/24.2.269

Bleomycin-induced chromosome breaks as a risk marker for lung cancer : A case-control study with population and hospital controls. / Zheng, Yun Ling; Loffredo, Christopher A.; Yu, Zhipeng; Jones, Raymond T.; Krasna, Mark J.; Alberg, Anthony J.; Yung, Rex; Perlmutter, Donna; Enewold, Lindsey; Harris, Curtis C.; Shields, Peter G.

In: Carcinogenesis, Vol. 24, No. 2, 01.02.2003, p. 269-274.

Research output: Contribution to journalArticle

Zheng, YL, Loffredo, CA, Yu, Z, Jones, RT, Krasna, MJ, Alberg, AJ, Yung, R, Perlmutter, D, Enewold, L, Harris, CC & Shields, PG 2003, 'Bleomycin-induced chromosome breaks as a risk marker for lung cancer: A case-control study with population and hospital controls', Carcinogenesis, vol. 24, no. 2, pp. 269-274. https://doi.org/10.1093/carcin/24.2.269
Zheng, Yun Ling ; Loffredo, Christopher A. ; Yu, Zhipeng ; Jones, Raymond T. ; Krasna, Mark J. ; Alberg, Anthony J. ; Yung, Rex ; Perlmutter, Donna ; Enewold, Lindsey ; Harris, Curtis C. ; Shields, Peter G. / Bleomycin-induced chromosome breaks as a risk marker for lung cancer : A case-control study with population and hospital controls. In: Carcinogenesis. 2003 ; Vol. 24, No. 2. pp. 269-274.
@article{378667cd952642bcb602159e5e7b1a15,
title = "Bleomycin-induced chromosome breaks as a risk marker for lung cancer: A case-control study with population and hospital controls",
abstract = "Environmental exposure to carcinogens and individual susceptibility play significant roles in cancer risk. Suboptimal DNA repair capability, measured by quantifying mutagen-induced chromosome breaks, might explain variable host susceptibility to environmental carcinogens. In an ongoing lung cancer case-control study, we compared individual sensitivity to bleomycin-induced chromosome breaks in 152 non-small cell lung cancer patients with 94 population controls and 85 hospital controls with no history of cancer. Mutagen sensitivity was measured by mean number of chromatid breaks per cell in cultured peripheral blood lymphocytes treated with bleomycin. Non-parametric tests and χ2 tests were used to determine the statistical significance of the crude case-control comparisons, followed by logistic regression to adjust for important covariates. The mean number of bleomycin-induced breaks per cell was 1.01 for the cases compared with 0.86 for hospital controls (P <0.01) and 0.89 for population controls (P <0.01). The mean number of breaks per cell was 1.01 for those >65 years old and 0.81 for those ≤65 years old (P <0.01) among population controls. Defining bleomycin sensitive as >0.84 break/cell (the median level in population controls), 67{\%} of the cases were bleomycin sensitive compared with 49{\%} of the hospital controls [adjusted odds ratio (OR) = 2.69, 95{\%} confidence interval (CI) = 1.44, 5.04], and 51{\%} of the population controls (adjusted OR = 2.18, 95{\%} CI = 1.13, 4.21). Our data indicate that the increased number of bleomycin-induced chromosome breaks was significantly associated with an increased risk of lung cancer in the first 331 subjects.",
author = "Zheng, {Yun Ling} and Loffredo, {Christopher A.} and Zhipeng Yu and Jones, {Raymond T.} and Krasna, {Mark J.} and Alberg, {Anthony J.} and Rex Yung and Donna Perlmutter and Lindsey Enewold and Harris, {Curtis C.} and Shields, {Peter G.}",
year = "2003",
month = "2",
day = "1",
doi = "10.1093/carcin/24.2.269",
language = "English (US)",
volume = "24",
pages = "269--274",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Bleomycin-induced chromosome breaks as a risk marker for lung cancer

T2 - A case-control study with population and hospital controls

AU - Zheng, Yun Ling

AU - Loffredo, Christopher A.

AU - Yu, Zhipeng

AU - Jones, Raymond T.

AU - Krasna, Mark J.

AU - Alberg, Anthony J.

AU - Yung, Rex

AU - Perlmutter, Donna

AU - Enewold, Lindsey

AU - Harris, Curtis C.

AU - Shields, Peter G.

PY - 2003/2/1

Y1 - 2003/2/1

N2 - Environmental exposure to carcinogens and individual susceptibility play significant roles in cancer risk. Suboptimal DNA repair capability, measured by quantifying mutagen-induced chromosome breaks, might explain variable host susceptibility to environmental carcinogens. In an ongoing lung cancer case-control study, we compared individual sensitivity to bleomycin-induced chromosome breaks in 152 non-small cell lung cancer patients with 94 population controls and 85 hospital controls with no history of cancer. Mutagen sensitivity was measured by mean number of chromatid breaks per cell in cultured peripheral blood lymphocytes treated with bleomycin. Non-parametric tests and χ2 tests were used to determine the statistical significance of the crude case-control comparisons, followed by logistic regression to adjust for important covariates. The mean number of bleomycin-induced breaks per cell was 1.01 for the cases compared with 0.86 for hospital controls (P <0.01) and 0.89 for population controls (P <0.01). The mean number of breaks per cell was 1.01 for those >65 years old and 0.81 for those ≤65 years old (P <0.01) among population controls. Defining bleomycin sensitive as >0.84 break/cell (the median level in population controls), 67% of the cases were bleomycin sensitive compared with 49% of the hospital controls [adjusted odds ratio (OR) = 2.69, 95% confidence interval (CI) = 1.44, 5.04], and 51% of the population controls (adjusted OR = 2.18, 95% CI = 1.13, 4.21). Our data indicate that the increased number of bleomycin-induced chromosome breaks was significantly associated with an increased risk of lung cancer in the first 331 subjects.

AB - Environmental exposure to carcinogens and individual susceptibility play significant roles in cancer risk. Suboptimal DNA repair capability, measured by quantifying mutagen-induced chromosome breaks, might explain variable host susceptibility to environmental carcinogens. In an ongoing lung cancer case-control study, we compared individual sensitivity to bleomycin-induced chromosome breaks in 152 non-small cell lung cancer patients with 94 population controls and 85 hospital controls with no history of cancer. Mutagen sensitivity was measured by mean number of chromatid breaks per cell in cultured peripheral blood lymphocytes treated with bleomycin. Non-parametric tests and χ2 tests were used to determine the statistical significance of the crude case-control comparisons, followed by logistic regression to adjust for important covariates. The mean number of bleomycin-induced breaks per cell was 1.01 for the cases compared with 0.86 for hospital controls (P <0.01) and 0.89 for population controls (P <0.01). The mean number of breaks per cell was 1.01 for those >65 years old and 0.81 for those ≤65 years old (P <0.01) among population controls. Defining bleomycin sensitive as >0.84 break/cell (the median level in population controls), 67% of the cases were bleomycin sensitive compared with 49% of the hospital controls [adjusted odds ratio (OR) = 2.69, 95% confidence interval (CI) = 1.44, 5.04], and 51% of the population controls (adjusted OR = 2.18, 95% CI = 1.13, 4.21). Our data indicate that the increased number of bleomycin-induced chromosome breaks was significantly associated with an increased risk of lung cancer in the first 331 subjects.

UR - http://www.scopus.com/inward/record.url?scp=0037328880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037328880&partnerID=8YFLogxK

U2 - 10.1093/carcin/24.2.269

DO - 10.1093/carcin/24.2.269

M3 - Article

C2 - 12584177

AN - SCOPUS:0037328880

VL - 24

SP - 269

EP - 274

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 2

ER -